Melatonin Protects Myocardium from Ischemia-Reperfusion Injury in Hypertensive Rats: Role of Myeloperoxidase Activity
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 30 (7) , 673-681
Abstract
Increased levels of reactive oxygen species, alterations in nitric oxide synthesis, and increased migration of neutrophils to the ischemic tissue play an important role in the pathophysiology of myocardial ischemia-reperfusion (IR) injury. In this study, we have evaluated the effects of melatonin on myeloperoxidase (MPO) activity, tissue glutathione (GSH), lipid peroxidation levels, and blood pressure in L-NAME-induced hypertensive rats with or without IR. NOS inhibitor L-NAME was administrated before inducing cardiac ischemia for 15 days intraperitoneally. For the cardiac ischemia, the left coronary artery was ligated for 30 min, and reperfusion was performed for 120 min after the ischemia. L-NAME treatment in non-ischemic animals increased blood pressure and lipid peroxidation, and decreased glutathione level in myocardial tissue significantly as compared with non-L-NAME-treated animals. Melatonin reversed L-NAME-induced blood pressure elevation and oxidative changes. Cardiac IR increased MDA levels and MPO activity and decreased GSH levels as compared with non-ischemic animals. L-NAME treatment did not change in IR-induced MDA and GSH levels as compared with ischemic control animals. However, MPO activity was significantly higher than control ischemic animals. MDA levels and MPO activity resulting from ischemic injury in melatonin-treated animals were significantly less than L-NAME-treated animals. Taken together—the ischemic and non-ischemic control and melatonin-treated animals—this study shows that neutrophil migration plays an important role on the development of ischemic injury in hypertensive rats.Keywords
This publication has 33 references indexed in Scilit:
- Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive RatsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Effects of Angiotensin II Type 1 Receptor Blockade on the Systemic Blood Nitric Oxide Dynamics in N.OMEGA.-Nitro-L-Arginine Methyl Ester-Treated RatsHypertension Research, 2006
- Nitric oxide synthase inhibition in rats: Melatonin reduces blood pressure and ischemia/reperfusion-induced infarct sizeScandinavian Cardiovascular Journal, 2006
- Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in HypertensionHypertension, 2004
- Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertensionJournal Of Hypertension, 2004
- Endothelial Function and Oxidative StressEndothelium, 2004
- Melatonin Protects Against Mercury(II)‐Induced Oxidative Tissue Damage in RatsBasic & Clinical Pharmacology & Toxicology, 2003
- Effects of physiological and pharmacological concentrations of melatonin on ischemia–reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced?Journal of Pineal Research, 2002
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumJournal of Pharmacological Methods, 1985
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982